Patents Represented by Attorney Myrexis, Inc. IP Group

Find this attorney in the Justia Lawyer Directory

  • Method of treating brain cancer
    Patent number: 8258145
    Abstract: Disclosed are 4-arylamino-quinazolines and analogs thereof effective as activators of caspases and inducers of apoptosis. The compounds of this invention are useful in the treatment of a variety of clinical conditions in which uncontrolled growth and spread of abnormal cells occurs, and in particular to the use of these compounds in treating brain cancer.
    Type: Grant
    Filed: July 3, 2007
    Date of Patent: September 4, 2012
    Assignee: Myrexis, Inc.
    Inventors: Sui Xiong Cai, Mark B. Anderson, Adam Willardsen, Nilantha Sudath Sirisoma